Is the FDA selling out? (Food and Drug Administration)(Fed Ache! How Bureaucrats Play Politics with Your Health)(Cover Story) From: Insight on the News | Date: July 7, 1997| Author: Berlau, John | COPYRIGHT 1997 News World Communications, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group.Copyright information

Critics see many reasons why reform is needed at the FDA. It is being investigated by the FBI and a House subcommittee on Oversight and Investigation. Doctors are complaining of long delays in new drug approvals. Several possible ethical lapses are discussed.

The Food and Drug Administration is the advocate for public health. Critic, however, charge the agency is substituting politics for science. Now, the FBI and a House subcommittee have launched probes.

The Food and ...

Related newspaper, magazine, and journal articles from HighBeam Research

	It's time for change at FDA. (Food and Drug Administration) Chain Drug Review ; Focus Despite the recent perorations of FDA Commissioner David Kessler, these are not the Food and Drug Administration's finest hours. Indeed, observers of government regulatory effectiveness, results and behavior would be hard put find an occasion when a government agency has been so continuously
	FDA-Barr debacle. (Food and Drug Administration threatens to close Barr Laboratories) (RX Mass Market Retail Pharmacy) (Editorial) Chain Drug Review ; One of the more disheartening news stories of 1991 was the ongoing battle between Barr Laboratories and the Food and Drug Administration. What makes it especially ...
	FDA explores new policies.(Food and Drug Administration)(Good Manufacturing Practice) Snack Food & Wholesale Bakery ; In March, U.S. Health and Human Services Secretary Tommy G. Thompson made headlines by releasing a new Food and Drug Administration (FDA) report outlining a strategy for combating the epidemic of obesity with a focus on the message, calories count The report by FDA's Obesity Working Group included
	IOM report faults FDA for lack of postmarketing focus.(Institute of Medicine)(Food and Drug Administration) Family Practice News ; The Food and Drug Administration should shift its emphasis from the preapproval period to postmarketing, when new drugs pose the greatest risk of safety problems, a sweeping report from the Institute of Medicine recommends. Numerous safety-related issues over the past few years--including the
	Report faults FDA for lack of postmarketing focus.(Food and Drug Administration) Skin & Allergy News ; The Food and Drug Administration should shift its emphasis from the preapproval period to postmarkethag, when new drugs pose the greatest risk of safety problems, a sweeping report from the Institute of Medicine recommends. Many safety-related issues in recent years--including the widely publicized

See all results.